Handheld Device Assesses Head Trauma Patients
By HospiMedica International staff writers Posted on 11 Oct 2016 |
Image: The BrainScope Ahead 300 device measures EEG at the point of care (Photo courtesy of BrainScope).
A novel multi-modal device offers a comprehensive panel of data to assist in the diagnosis of the full spectrum of traumatic brain injury (TBI).
The BrainScope Ahead 300 device uses proprietary electroencephalography (EEG) capabilities, several sophisticated algorithms, and machine learning to analyze head-injury data. By leveraging state-of-the-art smartphone-based technology and a proprietary disposable electrode headset, the Ahead 300 can provide rapid, objective assessment of the likelihood of the presence of TBI in patients who present with mild symptoms at the point of care. The device can also provide a digitized, streamlined report detailing a comprehensive and objective panel of results to facilitate differential diagnosis.
Developed in partnership with the U.S. Department of Defense (DOD; Washington, DC, USA), the system consists of a monitoring handset, dedicated software and algorithms for EEG acquisition and analysis and patient stratification, a disposable electrode headset, and a web-based application for centralized storage and review of patient data. The Ahead 300 is a product of Brainscope (Bethesda, MD, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“The Ahead 300 provides the specific capabilities needed today for the clinician to undertake a comprehensive assessment addressing the full spectrum of traumatic brain injury, from structural injuries visible on a CT scan, through mild TBI, also known as concussion,” said Michael Singer, CEO of BrainScope. “Our FDA clearance represents many years of development with our partner, the DOD. We are particularly grateful for the strong, continuing partnership which has led to this outstanding outcome.”
Head injury is the leading cause of death and disability in people under 45 years of age in developed countries, mostly resulting from falls and road accidents. The primary injury is caused by the initial mechanical force, which is followed by a secondary injury that develops in the hours and days afterwards, which is largely responsible for the patients' subsequent mental and physical disabilities.
Related Links:
U.S. Department of Defense
Brainscope
The BrainScope Ahead 300 device uses proprietary electroencephalography (EEG) capabilities, several sophisticated algorithms, and machine learning to analyze head-injury data. By leveraging state-of-the-art smartphone-based technology and a proprietary disposable electrode headset, the Ahead 300 can provide rapid, objective assessment of the likelihood of the presence of TBI in patients who present with mild symptoms at the point of care. The device can also provide a digitized, streamlined report detailing a comprehensive and objective panel of results to facilitate differential diagnosis.
Developed in partnership with the U.S. Department of Defense (DOD; Washington, DC, USA), the system consists of a monitoring handset, dedicated software and algorithms for EEG acquisition and analysis and patient stratification, a disposable electrode headset, and a web-based application for centralized storage and review of patient data. The Ahead 300 is a product of Brainscope (Bethesda, MD, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“The Ahead 300 provides the specific capabilities needed today for the clinician to undertake a comprehensive assessment addressing the full spectrum of traumatic brain injury, from structural injuries visible on a CT scan, through mild TBI, also known as concussion,” said Michael Singer, CEO of BrainScope. “Our FDA clearance represents many years of development with our partner, the DOD. We are particularly grateful for the strong, continuing partnership which has led to this outstanding outcome.”
Head injury is the leading cause of death and disability in people under 45 years of age in developed countries, mostly resulting from falls and road accidents. The primary injury is caused by the initial mechanical force, which is followed by a secondary injury that develops in the hours and days afterwards, which is largely responsible for the patients' subsequent mental and physical disabilities.
Related Links:
U.S. Department of Defense
Brainscope
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration